RESUMO
Galantamine, a drug currently approved for the treatment of Alzheimer's disease, has recently emerged as an effective pretreatment against the acute toxicity and delayed cognitive deficits induced by organophosphorus (OP) nerve agents, including soman. Since cognitive deficits can result from impaired glutamatergic transmission in the hippocampus, the present study was designed to test the hypothesis that hippocampal glutamatergic transmission declines following an acute exposure to soman and that this effect can be prevented by galantamine. To test this hypothesis, spontaneous excitatory postsynaptic currents (EPSCs) were recorded from CA1 pyramidal neurons in hippocampal slices obtained at 1h, 24h, or 6-9 days after guinea pigs were injected with: (i) 1×LD50 soman (26.3µg/kg, s.c.); (ii) galantamine (8mg/kg, i.m.) followed 30min later by 1×LD50 soman, (iii) galantamine (8mg/kg, i.m.), or (iv) saline (0.5ml/kg, i.m.). In soman-injected guinea pigs that were not pretreated with galantamine, the frequency of EPSCs was significantly lower than that recorded from saline-injected animals. There was no correlation between the severity of soman-induced acute toxicity and the magnitude of soman-induced reduction of EPSC frequency. Pretreatment with galantamine prevented the reduction of EPSC frequency observed at 6-9 days after the soman challenge. Prevention of soman-induced long-lasting reduction of hippocampal glutamatergic synaptic transmission may be an important determinant of the ability of galantamine to counter cognitive deficits that develop long after an acute exposure to the nerve agent.
Assuntos
Região CA1 Hipocampal/efeitos dos fármacos , Inibidores da Colinesterase/farmacologia , Potenciais Pós-Sinápticos Excitadores/efeitos dos fármacos , Galantamina/farmacologia , Células Piramidais/efeitos dos fármacos , Soman/farmacologia , Animais , Comportamento Animal/efeitos dos fármacos , Região CA1 Hipocampal/fisiologia , Inibidores da Colinesterase/toxicidade , Feminino , Cobaias , Células Piramidais/fisiologia , Soman/toxicidadeRESUMO
This study was designed to investigate the effects on single skeletal muscle fibers of a novel thienylhydrazone, referred to as LASSBio-294, which is a bioisoster of pyridazinone compounds that inhibit the cyclic AMP-specific phosphodiesterase (PDE) 4. Twitch and fatigue were analyzed in single skeletal muscle fibers isolated from either the semitendinous or the tibialis anterior muscles dissected from the frog Rana pipiens. LASSBio-294 (12.5-100 microM) increased twitch tension, accelerated the maximal rate of tension decay during relaxation, and had very little effect in the maximal rate of tension development of muscle fibers directly stimulated at < or =30 Hz. The positive inotropic effect of LASSBio-294 developed slowly, reaching its maximum at 40 min and was inversely proportional to the frequency of stimulation, becoming negligible at 60 and 90 Hz. The concentration-response relationship for LASSBio-294-induced potentiation of twitch tension was bell-shaped, with maximal effect occurring at 25 microM. In addition, LASSBio-294 reduced development of fatigue induced by tetanic stimulation of the muscle fibers and reduced the time needed for 80% prefatigue tension recovery after fatigue had developed to 50% of the maximal pretetanic force. These effects of LASSBio-294 can be fully explained by stimulation of the sarcoplasmic reticulum Ca2+ pump and could be ascribed to an increase in cellular levels of cyclic AMP due to PDE inhibition. The novel thienylhydrazone LASSBio-294 may be useful for treatment of patients suffering from conditions in which muscle fatigue is a debilitating symptom (e.g., chronic heart failure).
Assuntos
Cardiotônicos/farmacologia , Fadiga Muscular/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Potenciais de Ação/efeitos dos fármacos , Animais , Estimulação Elétrica , Hidrazonas/farmacologia , Técnicas In Vitro , Potenciais da Membrana/efeitos dos fármacos , Contração Muscular/efeitos dos fármacos , Fibras Musculares Esqueléticas/efeitos dos fármacos , Contração Miocárdica/efeitos dos fármacos , Rana pipiens , Tiofenos/farmacologiaRESUMO
In the present study, the patch-clamp technique was applied to cultured hippocampal neurons to evaluate the effects of the nerve agent VX on evoked and spontaneous postsynaptic currents mediated by gamma-aminobutyric acid (GABA) and glutamate. At 0.01 nM, VX reduced the amplitude of evoked GABAergic currents, and only at concentrations >1 nM did it decrease the amplitude of evoked glutamatergic currents. The effect of VX on GABAergic currents, which was partially reversible upon washing of the neurons with VX-free external solution, could be prevented by the muscarinic antagonist atropine. In contrast, the effect of VX on glutamatergic currents, which was not reversible upon washing, appears to be related to the VX-induced reduction of the amplitude and frequency of repetitively firing by action potentials. In the presence of the Na(+)-channel blocker tetrodotoxin (TTX), VX (>/=10 nM) increased the frequency of GABA- and glutamate-mediated miniature postsynaptic currents (MPSCs). This effect of VX was unrelated to cholinesterase inhibition and was Ca(2+) dependent. The lack of effect of VX on MPSC kinetics indicates that VX-induced alterations of evoked and spontaneous currents are exclusively due to alterations of the transmitter release processes. The ability of VX to affect transmitter release in the brain may underlie some of its neurotoxic effects and may provide the basis for the development of therapeutic countermeasures to treat and/or prevent VX-induced neurotoxicity.
Assuntos
Colinesterases/fisiologia , Potenciais Evocados/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Compostos Organofosforados/toxicidade , Compostos Organotiofosforados/toxicidade , Transmissão Sináptica/efeitos dos fármacos , Animais , Atropina/farmacologia , Cálcio/metabolismo , Células Cultivadas , Relação Dose-Resposta a Droga , Eletrofisiologia , Feminino , Glutamatos/farmacologia , Hipocampo/efeitos dos fármacos , Técnicas de Patch-Clamp , Gravidez , Ratos , Ratos Sprague-Dawley , Tetrodotoxina/farmacologia , Ácido gama-Aminobutírico/farmacologiaRESUMO
1. Dopamine is known to modulate glutamatergic synaptic transmission in the retina and in several brain regions by activating specific G-protein-coupled receptors. We have examined the possibility of a different type of mechanism for this modulation, one involving direct interaction of dopamine with ionotropic glutamate receptors. 2. Ionic currents induced by fast application of N-methyl-D-aspartate (NMDA) were recorded under whole-cell patch-clamp in cultured striatal, thalamic and hippocampal neurons of the rat and in retinal neurons of the chick. Dopamine at concentrations above 100 microM inhibited the NMDA response in all four neuron types, exhibiting an IC50 of 1.2 mM in hippocampal neurons. The time course of this inhibition was fast, developing in less than 100 ms. 3. The D1 receptor agonist (+)-SKF38393 mimicked the effect of dopamine, with an IC50 of 58.9 microM on the NMDA response, while the enantiomer (-)-SKF38393 was ineffective at 50 microM. However, the D1 antagonist R(+)-SCH23390 did not prevent the inhibitory effect of (+)-SKF38393. 4. The degree of inhibition by dopamine and (+)-SKF38393 depended on transmembrane voltage, increasing 2.7 times with a hyperpolarization of about 80 mV. The voltage-dependent block by dopamine was also observed in the presence of MgCl2 1 mM. 5. Single-channel recordings showed that the open times of NMDA-gated channels were shortened by (+)-SKF38393. 6. These data suggested that the site to which the drugs bound to produce the inhibitory effect was distinct from the classical D1-type dopamine receptor sites, possibly being located inside the NMDA channel pore. It is concluded that dopamine and (+)-SKF38393 are NMDA channel ligands.
Assuntos
2,3,4,5-Tetra-Hidro-7,8-Di-Hidroxi-1-Fenil-1H-3-Benzazepina/farmacologia , Cardiotônicos/farmacologia , Agonistas de Dopamina/farmacologia , Dopamina/farmacologia , Canais Iônicos/antagonistas & inibidores , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Receptores de N-Metil-D-Aspartato/metabolismo , Animais , Células Cultivadas , Embrião de Galinha , Corpo Estriado/citologia , Corpo Estriado/efeitos dos fármacos , Hipocampo/citologia , Hipocampo/efeitos dos fármacos , Ativação do Canal Iônico/efeitos dos fármacos , Canais Iônicos/fisiologia , Potenciais da Membrana/efeitos dos fármacos , N-Metilaspartato/farmacologia , N-Metilaspartato/fisiologia , Neurônios/efeitos dos fármacos , Neurônios/fisiologia , Ratos , Ratos Wistar , Receptores de N-Metil-D-Aspartato/fisiologia , Retina/citologia , Retina/efeitos dos fármacos , Estereoisomerismo , Tálamo/citologia , Tálamo/efeitos dos fármacosRESUMO
Recent data indicate that the neurotoxic effects of organophosphate compounds, including those of the nerve agents VX and sarin, are not solely due to irreversible cholinesterase inhibition. In this study we applied the patch clamp technique to hippocampal neurons in culture and slices to investigate the effects of VX, sarin and huperzine A on transmitter release and the mechanisms related with such effects. The nerve agents VX and sarin at very low concentrations significantly reduced the evoked release of GABA and glutamate. This effect was dependent of the activation of muscarinic receptors. In the presence or absence of the Na(+)-channel blocker tetrodotoxin (TTX), VX increased the frequency of spontaneous glutamate and GABA-induced postsynaptic currents. The effect of VX on TTX-insensitive spontaneous currents appears to be unrelated to cholinesterase inhibition, because it could be detected even after cholinesterase was blocked by high concentrations of the nerve agent soman. The ability of the nerve gases to decrease evoked release of GABA and increase spontaneous transmitter release may underlie some of the neurotoxic effects of the compounds. Huperzine A did not affect spontaneous or evoked release of GABA and glutamate, suggesting that this compound may be a pure cholinesterase inhibitor and had no effect on postsynaptic GABAA or AMPA receptors.
Assuntos
Inibidores da Colinesterase/toxicidade , Hipocampo/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Compostos Organofosforados/toxicidade , Sesquiterpenos/farmacologia , Alcaloides , Animais , Células Cultivadas , Técnicas de Cultura , Relação Dose-Resposta a Droga , Ácido Glutâmico/análise , Compostos Organotiofosforados/toxicidade , Técnicas de Patch-Clamp , Ratos , Sarina/toxicidade , Sesquiterpenos/uso terapêutico , Tetrodotoxina/farmacologia , Ácido gama-Aminobutírico/análiseAssuntos
Neurônios/fisiologia , Receptores Nicotínicos/fisiologia , Transmissão Sináptica/fisiologia , Regulação Alostérica , Animais , Cálcio/metabolismo , Permeabilidade da Membrana Celular , Hipocampo/citologia , Hipocampo/efeitos dos fármacos , Hipocampo/fisiologia , Humanos , Neurônios/efeitos dos fármacos , Agonistas Nicotínicos/farmacologia , Antagonistas Nicotínicos/farmacologia , Ratos , Receptores Nicotínicos/classificação , Receptores Nicotínicos/efeitos dos fármacosRESUMO
Methamidophos (O,S-dimethyl phosphoroamidothiolate, Tamaron), an organophosphate (OP) anticholinesterase of limited toxicity, is widely used as an insecticide and acaricide. To provide additional insight into the molecular basis of its action, we have used electrophysiological and biochemical techniques to study the effects of methamidophos on the neuromuscular junction of rat and frog and on the central nervous system of rat. Methamidophos has a relatively weak inhibitory action on cholinesterases in rat diaphragm muscle, brain and hippocampal homogenates, with IC50 values on the order of 20-20 microM. An even weaker anticholinesterase activity was found in frog muscle homogenates, with the IC50 being above 300 microM. As further evidence of anticholinesterase activity, methamidophos (1-100 microM) was able to reverse the blockade by d-tubocurarine (0.5-0.7 microM) of neuromuscular transmission in rat phrenic nerve-hemidiaphragm preparations. Inhibition of cholinesterase activity by methamidophos was long lasting, which is consistent with the formation by the agent of a covalent bond with the enzyme's active serine residue. The action was also slowly reversible, which suggests spontaneous reactivation of the enzyme. electrophysiological studies at the rat neuromuscular junction showed that, due to its anticholinesterase activity, methamidophos increased the amplitude and prolonged the decay phase of nerve-evoked and spontaneous miniature end-plate potentials. In contrast to other OP compounds, e.g., paraoxon (Rocha et al., 1996a), methamidophos did not affect neurotransmitter release, nor did it interact directly with the muscle nicotinic acetylcholine receptor. Moreover, it contrast to paraoxon, methamidophos did not affect the whole-cell currents induced by application of acetylcholine, glutamate or gamma-aminobutyric acid recorded to cultured hippocampal neurons. Based on these data, methamidophos appears to have a selective effect on cholinesterase.
Assuntos
Inibidores da Colinesterase/toxicidade , Inseticidas/toxicidade , Neurotransmissores/metabolismo , Compostos Organotiofosforados/toxicidade , Sinapses/efeitos dos fármacos , Animais , Diafragma/efeitos dos fármacos , Diafragma/inervação , Potenciais Evocados/efeitos dos fármacos , Técnicas In Vitro , Canais Iônicos/efeitos dos fármacos , Masculino , Placa Motora/efeitos dos fármacos , Contração Muscular/efeitos dos fármacos , Técnicas de Patch-Clamp , Ratos , Ratos Wistar , Sinapses/metabolismoRESUMO
The effects of lead (Pb++) on N-methyl-D-aspartate (NMDA) receptor function of rat hippocampal neurons in culture were studied by use of the whole-cell patch-clamp technique. Currents activated by NMDA (100 microM) in the presence of nonsaturating concentrations of glycine (0.01-0.05 microM) were potentiated in a voltage-independent manner by Pb++ (1-10 microM), and the potentiation was antagonized by 50 microM kynurenic acid. Increasing extracellular Ca++ from 1 to 10 mM similarly potentiated the NMDA-activated currents in the presence of a nonsaturating concentration of glycine (0.2 microM). The potentiation of NMDA-activated currents by low micromolar concentrations of Pb++ may be mediated by this cation's ability to increase the affinity of the NMDA receptor for glycine. In the presence of 10 microM glycine and 2 mM Ca++, Pb++ reduced the peak amplitudes of currents activated by NMDA (100 microM) in a voltage-independent manner (IC50 = 5.9 microM Pb++, Hill coefficient (nH) = 1.2). Also, steady-state currents activated by NMDA (50 microM) were inhibited by rapid application of Pb++ (IC50 = 3.2 microM, nH = 0.7). Increasing extracellular Ca++, in the presence of 10 microM glycine, reduced the NMDA-activated currents and shifted the Pb++ concentration-response curves to the right: at 0.2, 2 and 20 mM Ca++, the IC50 values of Pb++ were 3.0, 5.9 and 12.5 microM and the nH values were 0.9, 1.2 and 1.1, respectively. The finding that external Ca++ antagonized the inhibitory effect of Pb++ suggests that the noncompetitive inhibitory action of Pb++ with respect to glycine and NMDA may be mediated by Pb++ competition with Ca++ for a site on the NMDA receptor.
Assuntos
Cálcio/farmacologia , Glicina/farmacologia , Hipocampo/efeitos dos fármacos , Chumbo/toxicidade , Receptores de N-Metil-D-Aspartato/efeitos dos fármacos , Animais , Sítios de Ligação , Células Cultivadas , Relação Dose-Resposta a Droga , Hipocampo/fisiologia , Ácido Cinurênico/farmacologia , Chumbo/metabolismo , N-Metilaspartato/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores de N-Metil-D-Aspartato/fisiologiaRESUMO
Paraoxon (O,O-diethyl O-p-nitrophenyl phosphate) is the neurotoxic metabolite of the insecticide parathion (O,O-diethyl O-p-nitrophenyl phosphorothioate). The effects of organophosphorus compounds on peripheral synapses have been attributed to inhibition of cholinesterase and to direct actions on muscarinic and nicotinic receptors, but less is known about the actions of organophosphorus compounds, including paraoxon, in the central nervous system. We investigated initially the effects of paraoxon on spontaneous transmitter release by recording miniature postsynaptic currents (MPSCs) from cultured rat hippocampal neurons using the whole-cell mode of the patch-clamp technique. Paraoxon (0.3 microM) in the presence of tetrodotoxin (0.3 microM) and atropine (1 microM) caused a significant increase in the frequency of gamma-aminobutyric acid- and glutamate-mediated MPSCs, but did not change the peak amplitudes or decay-time constants of these MPSCs. In contrast, application of nicotinic agonists or antagonists did not change the MPSC frequency. The presynaptic effect of paraoxon shown here was not mediated by actions on muscarinic or nicotinic receptors, or by elevated acetylcholine levels secondary to inhibition of cholinesterase. In addition, agonists were applied to assess the postsynaptic effects of paraoxon on excitatory and inhibitory amino acid receptors. Paraoxon (30 microM-1 mM) blocked the ion channels of glycine, gamma-aminobutyric acidA, N-methyl-D-aspartic acid and nicotinic acetylcholine receptors, but not the ion channels of kalnate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors. The combined effects of paraoxon on spontaneous transmitter release and on the functions of several ligand-gated receptors may constitute mechanisms relevant to the neurotoxicity of paraoxon.
Assuntos
Hipocampo/efeitos dos fármacos , Paraoxon/farmacologia , Membranas Sinápticas/efeitos dos fármacos , Animais , Células Cultivadas , Colinesterases/metabolismo , Condutividade Elétrica , Glutamatos/farmacologia , Glicina/farmacologia , Hipocampo/citologia , Antagonistas Nicotínicos/farmacologia , Ratos , Receptores de AMPA/efeitos dos fármacos , Receptores de Glutamato/efeitos dos fármacos , Receptores de Glicina/efeitos dos fármacos , Receptores de Ácido Caínico/efeitos dos fármacos , Receptores Nicotínicos/efeitos dos fármacos , Ácido gama-Aminobutírico/farmacologiaRESUMO
A technique for dissociation of hippocampi of 3-25-day-old rats is described by which pyramidal and bipolar neurons with many long (up to 200 microns) dendrites can be obtained. Dissociation of CA1 neurons was achieved by mechanical means, in the absence of Ca2+, and without the use of proteolytic enzymes. The functional properties of the dissociated neurons were assessed using the whole-cell patch-clamp technique. Whole-cell currents were elicited by U-tube application of the agonists N-methyl-D-aspartate (NMDA), gamma-aminobutyric acid (GABA), and acetylcholine (ACh), and spontaneous miniature currents were also observed in these neurons. ACh-elicited currents were blocked by methyllycaconitine (MLA, 1 nM) and Pb2+ (0.1-10 microM). These results establish acutely dissociated neurons as a simple and reliable preparation for the study of the pharmacology, kinetics and subcellular distribution of ligand-gated ion channels.
Assuntos
Dendritos/fisiologia , Dendritos/ultraestrutura , Hipocampo/fisiologia , Ativação do Canal Iônico/fisiologia , Neurônios/fisiologia , Neurônios/ultraestrutura , Acetilcolina/farmacologia , Aconitina/análogos & derivados , Aconitina/farmacologia , Animais , Bungarotoxinas/farmacologia , Agonistas de Aminoácidos Excitatórios/farmacologia , Hipocampo/citologia , Chumbo/farmacologia , Ligantes , N-Metilaspartato/farmacologia , Bulbo Olfatório/citologia , Bulbo Olfatório/fisiologia , Bulbo Olfatório/ultraestrutura , Células Piramidais/efeitos dos fármacos , Células Piramidais/fisiologia , Células Piramidais/ultraestrutura , Ratos , Ratos Sprague-Dawley , Toxinas Biológicas/farmacologia , Ácido gama-Aminobutírico/farmacologiaRESUMO
Electrophysiological and biochemical studies demonstrated that pyrazole, an inhibitor of alcohol dehydrogenase and a proposed therapeutic agent for treatment of alcoholic intoxication, activated and blocked the N-methyl-D-aspartate (NMDA) receptor and did not interact significantly with the end-plate nicotinic acetylcholine receptor (AChR). Pyrazole, at concentrations as low as 0.5 microM, applied to outside-out patches excised from the membrane of cultured rat hippocampal neurons, elicited single-channel currents of 48 pS which were blocked by DL-2-amino-5-phosphorovaleric acid, a competitive antagonist of NMDA. In addition, binding studies showed that pyrazole displaced 1-(cis-2-carboxypiperidine-4-yl)methyl-1-phosphoric acid from the agonist recognition site of the NMDA receptor in a concentration-dependent manner and enhanced the binding of (+)-5-methyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-imine to this complex. These data indicate that pyrazole is an agonist at NMDA receptors. However, at higher concentrations, open and burst times as well as the frequency of single-channel currents activated by pyrazole were reduced significantly, a finding which suggests that this compound is also an open channel blocker. In agreement with these results, it was shown biochemically that pyrazole was able to stimulate influx of Ca++ into rat brain microsomes via NMDA receptors and on the other hand to block the influx of Ca++ induced by NMDA. Pyrazole was unable to affect the neuromuscular transmission of frog sartorius muscle-sciatic nerve preparations. Additionally, pyrazole did not interact either with the agonist recognition site or with noncompetitive sites of the AChR. However, this drug had a very weak agonist-like action on the AChR of the Torpedo electric organ, most likely via binding sites different from those described previously for acetylcholine. Therefore, the therapeutic efficacy of pyrazole may be related at least in part to its effects on the NMDA receptor. Furthermore, this compound, because of the small size and rigidity of its molecular structure, becomes a promising drug for the study of the NMDA receptor. Indeed its use may allow a better understanding of the physiological and pathological processes involving this receptor.
Assuntos
Hipocampo/efeitos dos fármacos , Pirazóis/farmacologia , Receptores de N-Metil-D-Aspartato/efeitos dos fármacos , Álcool Desidrogenase/antagonistas & inibidores , Animais , Anuros , Canais de Cálcio/efeitos dos fármacos , Células Cultivadas , Estimulação Elétrica , Masculino , Potenciais da Membrana/efeitos dos fármacos , Junção Neuromuscular/efeitos dos fármacos , Ratos , Ratos Endogâmicos , Receptores de N-Metil-D-Aspartato/metabolismo , TorpedoRESUMO
Several important physiological processes such as plasticity, memory, cell death, and rhythmic firing involve the N-methyl-D-aspartate (NMDA)-type of glutamatergic receptor. Nicotinic acetylcholine receptors (AChR), recently demonstrated in the central nervous system (CNS), are also of great interest. We have used several ligands to study the physiology and pharmacology of the agonist recognition sites of these receptors and kinetic properties of associated ion channels using whole-cell, cell-attached or outside-out variants of the patch-clamp technique. Enzymatically dissociated frog interosseal muscles were used to study peripheral AChRs, and tissue cultured or acutely dissociated hippocampal neurons and retinal ganglion cells (RGCs) for CNS receptors. For reproducible and fast solution changes when recording in the whole-cell configuration, we modified the "U"-shaped tube system to obtain different outputs from the same outflow port. We used fluorescent rhodamine-labeled latex microspheres to identify RGCs. Our studies provide important information regarding the molecular mechanisms of several clinically used agents. Additionally, similar actions of noncompetitive agents on the ion channels of the nicotinic ACh and NMDA receptors support the concept of a receptor ion channel superfamily.
Assuntos
Glutamatos/metabolismo , Receptores de Neurotransmissores/fisiologia , Receptores Nicotínicos/fisiologia , Animais , Células Cultivadas , Feminino , Humanos , Técnicas In Vitro , Canais Iônicos/efeitos dos fármacos , Músculos/fisiologia , Neurônios/efeitos dos fármacos , Neurônios/fisiologia , Neurotoxinas/farmacologia , Gravidez , Rana pipiens , Ratos , Ratos Endogâmicos , Receptores de Glutamato , Receptores de N-Metil-D-Aspartato/efeitos dos fármacos , Receptores de Neurotransmissores/efeitos dos fármacos , Receptores Nicotínicos/efeitos dos fármacosAssuntos
Etanol/farmacologia , Hipocampo/fisiologia , Músculos/fisiologia , Pirazóis/farmacologia , Receptores de N-Metil-D-Aspartato/fisiologia , Receptores Nicotínicos/fisiologia , Acetilcolina/farmacologia , Potenciais de Ação/efeitos dos fármacos , Animais , Anuros , Células Cultivadas , Feto , Técnicas In Vitro , Ativação do Canal Iônico/efeitos dos fármacos , Canais Iônicos/fisiologia , Ratos , Receptores de N-Metil-D-Aspartato/efeitos dos fármacos , Receptores Nicotínicos/efeitos dos fármacosRESUMO
The effects of MK-801 [( +]-5-methyl-10,11-dihydro-5H-di-benzo[a, d]cyclohepten-5,10-imine) on peripheral and central nicotinic receptors were studied using electrophysiological and biochemical techniques. MK-801 depressed the peak amplitude and accelerated the decay of end-plate currents. The drug (1-10 microM) decreased the frequency of activation of acetylcholine (ACh)-induced single-channel currents in addition to shortening the mean open and burst times of channels activated by either ACh or (+)anatoxin-a (AnTX). MK-801 (10-40 microM) depressed the single potentials and trains of ACh and AnTX-induced potentials in chronically denervated rat soleus muscles. MK-801 blocked the twitch responses (20-100 microM) of both frog sartorius and rat diaphragm muscles evoked by stimulation of their respective nerves. Also this drug (less than 1 microM) decreased the frequency of channels activated by AnTX or ACh in outside-out patch membranes of rat retinal ganglion cells with minimal changes in the channel open time. MK-801 (10-25 microM) depressed (-)nicotine-evoked gamma-amino[2,3-3H]butyric acid release from rat hippocampal synaptosomes; however, it failed to affect the binding of [3H](-)nicotine to brain membranes and also failed to interfere with the binding of [125I]alpha-bungarotoxin to either frog muscle or Torpedo membranes. On the other hand, MK-801 inhibited the binding of [3H]perhydrohistrionicotoxin to Torpedo membranes and such an effect was more pronounced in the presence of carbamylcholine. Neither AnTX nor any other nicotinic agonist increased the binding of [3H]MK-801 to the N-methyl-D-aspartate receptor ion channel complex. The actions of MK-801 were evident at concentrations comparable with those needed to block N-methyl-D-aspartate receptors. These results demonstrate the existence of at least three different types of nicotinic AChR, all of which were blocked noncompetitively by MK-801.
Assuntos
Anticonvulsivantes/farmacologia , Toxinas Bacterianas , Encéfalo/efeitos dos fármacos , Dibenzocicloeptenos/farmacologia , Canais Iônicos/efeitos dos fármacos , Receptores Nicotínicos/efeitos dos fármacos , Acetilcolina/farmacologia , Animais , Toxinas de Cianobactérias , Maleato de Dizocilpina , Técnicas In Vitro , Toxinas Marinhas/farmacologia , Microcistinas , Músculos/efeitos dos fármacos , Rana pipiens , Ratos , Ratos Endogâmicos , Receptores de N-Metil-D-Aspartato , Receptores de Neurotransmissores/efeitos dos fármacos , Receptores Nicotínicos/metabolismo , Células Ganglionares da Retina/efeitos dos fármacos , Tropanos , Ácido gama-Aminobutírico/metabolismoRESUMO
N,N-dimethylanatoxin (DMAnTX), the quaternary derivative of the potent nicotinic agonist (+)-anatoxin-a (AnTX), has been evaluated for potency and efficacy at nicotinic acetylcholine receptors of frog motor endplates and Torpedo electric organs. DMAnTX was only weakly effective in eliciting contracture of the frog rectus abdominis and was orders of magnitude less potent than AnTX. Biochemical assay showed that DMAnTX was a weak inhibitor of [125I]alpha-bungarotoxin binding to the receptors in frog muscle and Torpedo electroplaque membranes: the IC50 values were 60 and 14 microM, respectively. A low frequency of single channel currents recorded from isolated interosseal fibers at concentrations from 20 to 100 microM of DMAnTX and the stimulation of [3H]perhydrohistrionicotoxin [( 3H]H12-HTX) binding (half-maximal at 0.3 microM) confirmed the weak activation of the receptor. DMAnTX also exhibited antagonist effects. In muscle twitch assays, 100 microM of DMAnTX effectively decreased the tension induced by nerve stimulation, although DMAnTX did not affect muscle membrane action potentials. The binding of [3H] perhydrohistrionicotoxin was also inhibited at high micromolar concentrations of DMAnTX. Combination of DMAnTX with acetylcholine in single channel current experiments demonstrated that DMAnTX possesses ion channel blocking properties, which become apparent at low micromolar concentrations, and DMAnTX enhances the desensitization induced by acetylcholine above 10 microM AnTX. The difference in agonist potency between AnTX and DMAnTX may be attributed to a change in conformation of the molecular skeleton induced by the N-methyl groups.
Assuntos
Toxinas Bacterianas , Dimetilaminas/farmacologia , Toxinas Marinhas/farmacologia , Receptores Nicotínicos/efeitos dos fármacos , Acetilcolina/farmacologia , Potenciais de Ação/efeitos dos fármacos , Venenos de Anfíbios/metabolismo , Animais , Bungarotoxinas/metabolismo , Toxinas de Cianobactérias , Técnicas In Vitro , Canais Iônicos/efeitos dos fármacos , Microcistinas , Conformação Molecular , Contração Muscular/efeitos dos fármacos , Rana pipiens , Torpedo , TropanosRESUMO
The effects of (+)- and (-)-anatoxin-a (AnTX) and N-methylanatoxin (M-AnTX) on peripheral nicotinic ion channel activity were studied using high micromolar concentrations. Whereas (+)-AnTX is an effective agonist at nanomolar concentrations, (-)-AnTX and M-AnTX were effective at low micromolar concentrations. The binding of [3H]perhydrohistrionicotoxin to the nicotinic acetylcholine receptor-ion channel was stimulated by the above agonist concentrations, but [3H]perhydrohistrionicotoxin binding was inhibited at high micromolar concentrations of each of the toxins. In single channel recordings, these toxins exhibited ion channel blocking properties; the concentration- and voltage-dependent kinetics of each were essentially the same. In the case of (+)-AnTX, desensitization was also present at micromolar concentrations. These data show that ion channel blockade may be a property of many anatoxin-a analogs, and that in the particular case of analogs with low agonist potency, ion channel blockade may be a concomitant primary effect of the toxins. Stereospecificity and number of amine moieties did not influence the ion channel blocking characteristics in this series of molecules, although these factors strongly modified agonist potency.
Assuntos
Toxinas Bacterianas , Compostos Bicíclicos Heterocíclicos com Pontes , Compostos Bicíclicos com Pontes/farmacologia , Hidrocarbonetos Aromáticos com Pontes/farmacologia , Canais Iônicos/efeitos dos fármacos , Toxinas Marinhas/farmacologia , Receptores Colinérgicos/efeitos dos fármacos , Venenos de Anfíbios/metabolismo , Animais , Anuros , Bungarotoxinas/metabolismo , Toxinas de Cianobactérias , Relação Dose-Resposta a Droga , Técnicas In Vitro , Microcistinas , Estereoisomerismo , Torpedo , TropanosRESUMO
The multiple actions of nicotine enantiomers at the peripheral nicotinic acetylcholine receptor were evaluated using electrophysiological and biochemical techniques. The alpha-bungarotoxin binding site showed a 6-fold greater affinity for (-)-nicotine than for the (+)-isomer, and this stereoselectivity was reflected in differences in the ability of the alkaloids to activate physiological responses in the forms of single ion channel currents, endplate depolarizations and muscle contractures. (-)-Nicotine was also more potent to induce slow desensitization. In contrast, both (-)- and (+)-nicotine were equipotent as ion channel blockers. Ion channel blockade occurred at effective agonist concentrations for (+)-nicotine but above the effective concentration for (-)-nicotine. The rapid and reversible interaction of nicotine enantiomers with the ion channel occurred at concentrations which implicate a significant contribution of channel blockade to the inhibition of indirect muscle twitch. The agonistic and ion channel blocking effects of the nicotine enantiomers provide important clues regarding the mechanisms by which nicotine may affect central nervous system nicotinic receptors.
Assuntos
Canais Iônicos/efeitos dos fármacos , Nicotina/farmacologia , Receptores Nicotínicos/efeitos dos fármacos , Animais , Sítios de Ligação , Bungarotoxinas/metabolismo , Técnicas In Vitro , Cinética , Potenciais da Membrana/efeitos dos fármacos , Contração Muscular/efeitos dos fármacos , Junção Neuromuscular/efeitos dos fármacos , Rana pipiens , EstereoisomerismoRESUMO
Using biochemical and patch-clamp techniques, we investigated the pharmacology of S- and R-epimers of N-methylanatoxinol, which are analogs of the semi-rigid, stereoselective, nicotinic agonist (+)-anatoxin-a. In contrast to (+)-anatoxin-a, both isomers had poor ability to inhibit the binding of 125I-alpha-bungarotoxin or to open acetylcholine channels, and they were unable to elicit contracture of frog rectus abdominis muscles. However, both isomers were able to demonstrate significant concentration-dependent blockade of the nicotinic acetylcholine receptor ion channel. The R-isomer was approximately 4-fold more potent in causing inhibition of [3H]H12HTX binding than was the S-isomer, in the absence of carbamylcholine. In the presence of carbamylcholine, the affinity of the R-isomer of N-methylanatoxinol for the ion channel sites was further enhanced, so that its affinity became much greater than that of the S-isomer. Refinement of voltage- and concentration-dependent terms for the ion channel blocking and unblocking rates yielded functions that were able to predict the channel open times and short closed times well. The S-isomer bound and dissociated from the ion channel site of the nicotinic acetylcholine receptor more rapidly and with greater voltage sensitivity than the R-isomer. The present characterization of the antagonistic properties of these new analogs of (+)-anatoxin-a introduces a new aspect to the molecular pharmacology of (+)-anatoxin-a analogs; the semi-rigid compounds could be useful in describing the allosteric binding sites of the acetylcholine receptor, as well as in delimiting the agonist binding site.
Assuntos
Toxinas Bacterianas , Compostos Bicíclicos Heterocíclicos com Pontes , Compostos Bicíclicos com Pontes/farmacologia , Hidrocarbonetos Aromáticos com Pontes/farmacologia , Canais Iônicos/efeitos dos fármacos , Toxinas Marinhas/farmacologia , Receptores Nicotínicos/efeitos dos fármacos , Animais , Sítios de Ligação , Toxinas de Cianobactérias , Relação Dose-Resposta a Droga , Técnicas In Vitro , Microcistinas , Contração Muscular/efeitos dos fármacos , Rana pipiens , Estereoisomerismo , Relação Estrutura-Atividade , TropanosRESUMO
1. We have shown that all cholinesterase (ChE) inhibitors, in addition to their well-known anti-ChE activity, have multiple effects on the nicotinic acetylcholine receptor-ion channel (AChR) macromolecule resulting from interactions with the agonist recognition site and with sites located at the ion channel component. Activation, competitive antagonism and different types of noncompetitive blockade occurring at similar concentration ranges and contributing in different proportions result in complex and somewhat unpredictable alterations in AChR function. The question is now raised as to how each effect of these compounds contributes to their antidotal property against organophosphorus (OP) poisoning, and what set of actions makes one reversible ChE inhibitor a better antidote. Many lines of evidence support the importance of direct interactions with various sites on the AChR: 1) morphological and toxicological studies with (+) physostigmine showed that anti-ChE activity is not essential to protect animals against toxicity by irreversible ChE inhibitors; 2) (-)physostigmine is far more effective against OP poisoning; 3) open channel blockers such as mecamylamine with no significant anti-ChE activity enhance the protective action of (-)physostigmine; 4) neostigmine, pyridostigmine, (-)physostigmine and (+)physostigmine showed qualitatively and quantitatively distinct toxicity and damage to endplate morphology and function. 2. In prophylaxis and during the very early phase of OP poisoning, carbamates, especially (-)physostigmine combined with mecamylamine and atropine, could protect almost 100% of the animals exposed to multiple lethal doses of OPs. Electrophysiological data showed that (-)physostigmine, among several reversible ChE inhibitors, showed greater potency in depressing both endplate current (EPC) peak amplitude and tau EPC. Therefore, concerning neuromuscular transmission, it seems that the higher the potency of a drug in reducing endplate permeability, the better is its protection against OP toxicity. A reversible open channel blockade combined with some agonist property helps to decrease the effect of ACh at its agonist site and to reduce the ion permeability of open channels. It should be pointed out that, during the later phase of OP poisoning, AChR desensitization should be most prevalent. Thus, a drug that can remove the AChR from this rather irreversible state to a more reversible blocked state should be a better protector. Indeed, oximes such as 2-PAM and a more potent analog, HI-6, produce multiple alterations in AChR function that comprise increased channel activation and open-channel blockade.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
Inibidores da Colinesterase/farmacologia , Intoxicação por Organofosfatos , Receptores Nicotínicos/efeitos dos fármacos , Animais , Sítios de Ligação , Fenômenos Químicos , Química , Inibidores da Colinesterase/metabolismo , Edrofônio/farmacologia , Contração Muscular/efeitos dos fármacos , Neostigmina/farmacologia , Fisostigmina/farmacologia , Brometo de Piridostigmina/farmacologia , Rana pipiens , Receptores Nicotínicos/metabolismo , Nervo Isquiático/efeitos dos fármacos , Relação Estrutura-AtividadeRESUMO
We have shown that alt cholinesterase (ChE) inhibitors, in addition to their well-known anti-ChE activity, have multiple effects on the nicotinic acetylcholine receptor-ion channel (AChR) macromolecule resulting from interactions with the agonist recognition site and with sites located at the ion channel component. Activation, competitive antagonism and different types of noncompetitive blockade occurring at similar concentration ranges and contributing in different proportions result in complex and somewhat unpredictable alterations inn AChR function. The question is now raised as to how each effect of these compounds contributes to their antidotal property against organophosphorus (OP) poisoning, and what set of actions makes one reversible ChE inhibitor a better antidote. Many lines of evidence support the importance of direct interactions with various sites on the AChR: 1) morphological and toxicological studies with (+) physostigmine showed that anti-ChE activity is not essential to protect animals against toxicity by irreversible ChE inhibitors; 2) (-) physostigmine is far more effective against OP poisoning; 3) open channel blockers such as mecamylamine with no significant anti-ChE activity enhance the protective action of (-) physostigmine; 4) neostigmine, pyridostigmine, (-) physostigmine and (+) physostigmine showed qualitatively and quantitatively distinct toxicity and damage to endplate morphology and function. In prophylaxis and during the very early phase of OP poisoning, carbamates, especially (-) physostigmine combined with mecamylamine and atropine, could protect almost 100% of the animals exposed to multiple lethal doses of OPs...